Islamic medicine||163.56 International Union of Basic and Clinical Pharmacology||157.02 David Macht||104.67 The Canon of Medicine||85.05 Gideon Koren||78.51 Neuropsychopharmacology (journal)||77.3 Receptor antagonist||71.96 British Pharmacological Society||71.96 Ethnopharmacology||71.12 Eglumegad||65.42 RB-101||65.42 Ibogaine||58.88 John Jacob Abel||58.88 Short-term effects of alcohol||58.88 Gholam Mujtaba||52.34 Rat Park||52.34 Eseroline||52.34 Rudolf Buchheim||52.34 Alexander Shulgin||52.34 Ahmad-Reza Dehpour||52.34 Neuropharmacology||47.81 Lobeline||45.79 Dalian Medical University||45.79 Louis Ignarro||45.79 Joseph Schlessinger||45.79 Medical psychology||44.05 V. Craig Jordan||39.25 Kee Chang Huang||39.25 University of Appalachia College of Pharmacy||39.25 University of Arizona College of Pharmacy||39.25 Tebanicline||39.25 David Colquhoun||39.25 Diclofensine||39.25 Louis Lasagna||39.25 Nefopam||39.25 University of the Sciences in Philadelphia||39.25 Rainer Liedtke||39.25 Maurício Rocha e Silva||32.71 University of California at San Diego School of Medicine||32.71 Effective dose||32.71 Monika Schäfer-Korting||32.71 SNC-80||32.71 Y-23684||32.71 Ashok D B Vaidya||32.71 Dave Bailey (athlete)||32.71 Tracazolate||32.71 Baroda Medical College||32.71 Inverse agonist||32.71 Abecarnil||32.71